Artificial Intelligence: Alphabet To Commercialize AlphaFold2 AI For Drug Discovery

November 5, 2021 | Artificial Intelligence, News

Alphabet has launched a new company called Isomorphic Labs for drug discovery using AI.

Alphabet’s (NASDAQ: GOOGL) DeepMind unit made headlines with its path-breaking AI system AlphaFold2, which solved the 50-year-old challenge of protein folding. Alphabet is building on that breakthrough with the creation of Isomorphic Labs, a commercial venture that will bring an AI-centric approach to the entire drug discovery process. (The Verge)

The new company will be led by Demis Hassabis, who will continue to function also as CEO of DeepMind.

Isomorphic is envisioned as a pioneer in the field of “digital biology” that will achieve numerous biomedical breakthroughs, use AI to accelerate drug discovery, and find cures for terrible diseases that assail mankind.

“There may be a common underlying structure between biology and information science – an isomorphic mapping between the two – hence the name of the company,” writes Hassabis in a blog announcing the new company.

“Just as mathematics turned out to be the right description language for physics, biology may turn out to be the perfect type of regime for the application of AI,” he adds.

Commercial approach to drug discovery

“AI methods will increasingly be used not just for analysing data, but to also build powerful predictive and generative models of complex biological phenomena.”

In its commercial operations, Isomorphic Labs could use its AI skills to develop models that it will not convert into drugs – instead it may sell the models to pharmaceutical companies that it will partner with in the future.

Related Story: AI Solves 50-Year-Old Biology Mystery; Medical Breakthroughs Could Follow

Image Credit: ZNF691 Relative Protein Folding by Wikimedia Commons

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Latest Alternative Investment News
FinTech: LatAm BNPL Provider Kueski Nabs $202M Series C Round
December 3, 2021     FinTech, News, Venture Capital

Kueski is one of the largest buy-now-pay-later (BNPL) and digital lenders in Latin America. It announced December 2 its close of a $202 million Series C debt and equity round….
Digital Assets: Renowned Investor Charlie Munger Sides With China On Its Crypto Ban
December 3, 2021     Digital Assets, News

Charlie Munger has shot off another broadside against bitcoin, endorsing China’s action in banning cryptos. A long-standing bitcoin skeptic, Munger was speaking in an interview for the Sohn Hearts &…
Venture Capital: 15-Minute Delivery Startup JOKR Raises $260M Series B
December 3, 2021     News, Venture Capital

New York-based instant grocery delivery startup JOKR has become a unicorn within nine months of its launch and raised a $260 million Series B within five months of raising $170…
Venture Capital: Porsche Buys A Stake In Sustainable Homes-Focused Startup 1KOMMA5°

Porsche, the German car maker, has taken a stake in Hamburg-based startup 1KOMMA5° through its venture finance arm, Porsche Ventures. The startup seeks to boost the rollout of presently decentralized…